1. Home
  2. NBBK vs IVA Comparison

NBBK vs IVA Comparison

Compare NBBK & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NBBK
  • IVA
  • Stock Information
  • Founded
  • NBBK 1892
  • IVA 2011
  • Country
  • NBBK United States
  • IVA France
  • Employees
  • NBBK N/A
  • IVA N/A
  • Industry
  • NBBK
  • IVA Biotechnology: Pharmaceutical Preparations
  • Sector
  • NBBK
  • IVA Health Care
  • Exchange
  • NBBK Nasdaq
  • IVA Nasdaq
  • Market Cap
  • NBBK 722.1M
  • IVA 769.0M
  • IPO Year
  • NBBK N/A
  • IVA 2020
  • Fundamental
  • Price
  • NBBK $18.00
  • IVA $6.24
  • Analyst Decision
  • NBBK Buy
  • IVA Strong Buy
  • Analyst Count
  • NBBK 1
  • IVA 7
  • Target Price
  • NBBK $20.00
  • IVA $16.00
  • AVG Volume (30 Days)
  • NBBK 155.3K
  • IVA 61.2K
  • Earning Date
  • NBBK 10-29-2025
  • IVA 09-29-2025
  • Dividend Yield
  • NBBK 1.57%
  • IVA N/A
  • EPS Growth
  • NBBK 341.36
  • IVA N/A
  • EPS
  • NBBK 1.33
  • IVA N/A
  • Revenue
  • NBBK $179,117,000.00
  • IVA $19,929,536.00
  • Revenue This Year
  • NBBK N/A
  • IVA N/A
  • Revenue Next Year
  • NBBK N/A
  • IVA N/A
  • P/E Ratio
  • NBBK $13.43
  • IVA N/A
  • Revenue Growth
  • NBBK 28.24
  • IVA N/A
  • 52 Week Low
  • NBBK $15.09
  • IVA $1.60
  • 52 Week High
  • NBBK $21.05
  • IVA $6.55
  • Technical
  • Relative Strength Index (RSI)
  • NBBK 46.22
  • IVA 60.61
  • Support Level
  • NBBK $17.40
  • IVA $5.59
  • Resistance Level
  • NBBK $18.38
  • IVA $6.55
  • Average True Range (ATR)
  • NBBK 0.41
  • IVA 0.33
  • MACD
  • NBBK -0.07
  • IVA 0.01
  • Stochastic Oscillator
  • NBBK 39.39
  • IVA 78.02

About NBBK NB Bancorp Inc.

NB Bancorp Inc operates as the holding company of Needham Bank. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in commercial real estate and multifamily loans, one- to four-family residential real estate loans, construction and land development loans, commercial and industrial loans, and consumer loans.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Share on Social Networks: